Another Lawsuit Filed Over Fatal Xarelto Bleeding Event

Public Health Watchdog Breaking News
Public Health Watchdog Breaking News

A California man just filed a lawsuit against Janssen Pharmaceuticals—a subsidiary of Johnson & Johnson—the maker of the blood thinner, Xarelto (rivaroxaban). The lawsuit alleges the man’s now-deceased mother suffered a fatal Xarelto side effect.

The man also alleges that his late mother began taking Xarelto on or about September 2, 2014, continuing treatment until she suffered an intracranial hemorrhage on September 11, 2014. She died five days later on September 16, 2014. Allegations also include that Janssen was aware of the severe and fatal Xarelto side effects associated with its drug, but that the drug maker never appropriately advised the medical community and the public about these potential problems but, rather, continued its aggressive marketing of Xarelto as safe and effective.

Xarelto is typically prescribed for the treatment of blood clots, which may cause very serious conditions that may become fatal. In cases of extreme internal bleeding, the body uses blood clots to slow the bleeding. This natural process may stop an injured person from losing excessive amounts of blood. For patients taking a blood thinner, such as Xarelto, their bodies may not be able to create the life-saving blood clots needed when an internal bleeding injury occurs.

Xarelto received U.S. Food and Drug Administration (FDA) clearance in 2011 and was released to the market to treat patients who may be at an increased risk of developing blood clots or undergoing stroke due to medical conditions, including atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism. Xarelto is also approved for individuals recovering from hip or knee replacement surgery.

Soon after its release, Xarelto’s potentially serious side effects were revealed. Emerging studies found a possible tie to spontaneous and severe bleeding episodes. What’s more, there is no antidote to reverse bleeding events in patients taking Xarelto and other newer blood thinners, such as Pradaxa.

Xarelto patients may suffer from significant or fatal bleeding Xarelto side effects. Individuals who are involved in Xarelto internal bleeding lawsuits allege a variety of serious and fatal Xarelto side effects that may lead to permanent injury, including:

  • Bloody stool
  • Brain hemorrhaging
  • Gastrointestinal (GI) bleeding
  • Hemorrhaging
  • Hermarthrosis (bleeding into the spaces in joint)
  • Minor bleeding events such as nosebleeds and/or heavy menstrual flow
  • Rectal bleeding
  • Uterine bleeding
  • Vitreous bleeding (bleeding of the eyes)